Header Logo

Connection

DAVID LONARD to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications DAVID LONARD has written about Immunotherapy, Adoptive.
DAVID LONARD
Connection Strength
0.036
Immunotherapy, Adoptive
  1. CRISPR-Cas9 engineering of human T regulatory cells - Design and optimization of a manufacturing process. Mol Immunol. 2025 Aug; 184:13-21.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.